Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2020 | 2 |
2022 | 3 |
2023 | 1 |
Search Results
6
results
Results by year
Page 1
99mTc-PSMA Left Behind: a Call for Collaboration.
Nucl Med Mol Imaging. 2022 Aug;56(4):218-219. doi: 10.1007/s13139-022-00753-7. Epub 2022 Jun 6.
Nucl Med Mol Imaging. 2022.
PMID: 35846417
No abstract available.
Fact Checking on 177Lu Prostate-Specific Membrane Antigen Nephrotoxicity.
Askari E, Moghadam SZ, Aryana K.
Askari E, et al. Among authors: moghadam sz.
AJR Am J Roentgenol. 2020 Jul;215(1):W2. doi: 10.2214/AJR.19.22271.
AJR Am J Roentgenol. 2020.
PMID: 32568577
No abstract available.
Item in Clipboard
68 Ga-FAPI-46 PET/CT in a Metastatic Castration-Resistant Prostate Cancer Patient With Low PSMA Expression.
Aryana K, Manafi-Farid R, Amini H, Divband G, Moghadam SZ.
Aryana K, et al. Among authors: moghadam sz.
Clin Nucl Med. 2022 Nov 1;47(11):972-973. doi: 10.1097/RLU.0000000000004315. Epub 2022 Jul 6.
Clin Nucl Med. 2022.
PMID: 35777753
Item in Clipboard
Peptide Receptor Radionuclide Therapy in Merkel Cell Carcinoma: A Comprehensive Review.
Askari E, Moghadam SZ, Wild D, Delpassand E, Baldari S, Nilica B, Hartrampf PE, Kong G, Grana CM, Alexander Walter M, Capoccetti F, Kasi PM, Strosberg J.
Askari E, et al. Among authors: moghadam sz.
J Nucl Med Technol. 2023 Mar;51(1):22-25. doi: 10.2967/jnmt.122.264904. Epub 2022 Oct 4.
J Nucl Med Technol. 2023.
PMID: 36195446
Review.
Item in Clipboard
Whole-Body 177Lu-Prostate-Specific Membrane Antigen Scan Pattern With Excess Free 177Lu-Chloride in a Metastatic Castration-Resistant Prostate Cancer Patient.
Askari E, Moghadam SZ, Divband G, Aryana K.
Askari E, et al. Among authors: moghadam sz.
Clin Nucl Med. 2020 Oct;45(10):805-807. doi: 10.1097/RLU.0000000000003167.
Clin Nucl Med. 2020.
PMID: 32604118
Item in Clipboard
Favorable Response After Only One Cycle of Peptide Receptor Radionuclide Therapy With 177Lu-DOTATATE in a Patient With Metastatic Merkel Cell Carcinoma.
Moghadam SZ, Divband G, Shakeri S, Aryana K.
Moghadam SZ, et al.
Clin Nucl Med. 2019 Aug;44(8):650-652. doi: 10.1097/RLU.0000000000002669.
Clin Nucl Med. 2019.
PMID: 31274613
Item in Clipboard
Cite
Cite